Agios Pharmaceuticals logo

Agios Pharmaceuticals share price today

(AGIO)

Agios Pharmaceuticals share price is $33.4 & ₹2,856.97 as on 30 Dec 2024, 20.26 hrs IST

$33.4

▲

-0.97

(-2.82%)

Market is closed - opens 8 PM, 30 Dec 2024

View live Agios Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Agios Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Agios Pharmaceuticals. Get details on the Indian mutual funds that are investing in Agios Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Agios Pharmaceuticals's financials.

Agios Pharmaceuticals share price movements

  • Today's Low: $32.91
    Today's High: $34.41

    Day's Volatility :4.35%

  • 52 Weeks Low: $20.96
    52 Weeks High: $62.58

    52 Weeks Volatility :66.51%

Agios Pharmaceuticals Returns

PeriodAgios Pharmaceuticals, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-24.83%
-9.8%
0.0%
6 Months
-23.01%
-4.7%
0.0%
1 Year
46.3%
1.9%
0.0%
3 Years
1.61%
-1.8%
-21.3%

Agios Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$33.4
Open
$33.87
Today's High
$34.41
Today's Low
$32.76
Market Capitalization
$2.0B
Today's Volume
$827.9K
52 Week High
$62.58
52 Week Low
$20.96
Revenue TTM
$32.9M
EBITDA
$-401.3M
Earnings Per Share (EPS)
$11.66
PE Ratio
2.95
Profit Margin
2051.38%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
53.66%

How to invest in Agios Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Agios Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Agios Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Agios Pharmaceuticals or AGIO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Agios Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Agios Pharmaceuticals shares which would translate to 0.026 fractional shares of Agios Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Agios Pharmaceuticals, in just a few clicks!

Returns in Agios Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Agios Pharmaceuticals investment value today

Current value as on today

₹1,49,093

Returns

₹49,093

(+49.09%)

Returns from Agios Pharmaceuticals Stock

₹46,299 (+46.3%)

Dollar Returns

₹2,795 (+2.79%)

Indian investors sentiment towards Agios Pharmaceuticals

3550.0%

Period: Sep 30, 2024 to Dec 29, 2025. Change in 30 Days versus previous period

Investment in Agios Pharmaceuticals from India has grown in the last 30 days as on Dec 30, 2025. 3550.0% more purchase transactions for Agios Pharmaceuticals in the last 30 days versus the previous period.

163%

Period: Sep 30, 2024 to Dec 29, 2025. Change in 30 Days versus previous period

Search volume for Agios Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Dec 30, 2025. 163% more investors are searching Agios Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Agios Pharmaceuticals

  • Farallon Capital Management, L.L.C.

    9.93%

  • Vanguard Group Inc

    9.72%

  • BlackRock Inc

    8.52%

  • Bellevue Group AG

    6.55%

  • T. Rowe Price Associates, Inc.

    4.97%

  • State Street Corp

    4.09%

Analyst Recommendation on Agios Pharmaceuticals

Buy

    73%Buy

    26%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Agios Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
10
Hold
4
4
4
Sell
0
0
0

Analyst Forecast on Agios Pharmaceuticals

What analysts predicted

Upside of 71.51%

Current:

$33.40

Target:

$57.29

Insights on Agios Pharmaceuticals

  • Price Movement

    In the last 7 days, AGIO stock has moved down by -5.5%

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 7.10M → 8.96M (in $), with an average increase of 7.4% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -96.11M → 947.91M (in $), with an average increase of 110.1% per quarter

  • AGIO vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 39.1% return, outperforming this stock by 39.6%

Agios Pharmaceuticals Financials in INR & Dollars

FY18Y/Y Change
Revenue
$94.4M
↑ 119.45%
Net Income
$-346.0M
↑ 9.97%
Net Profit Margin
-366.61%
↑ 364.99%
FY19Y/Y Change
Revenue
$117.9M
↑ 24.92%
Net Income
$-396.6M
↑ 14.62%
Net Profit Margin
-336.36%
↑ 30.25%
FY20Y/Y Change
Revenue
$203.2M
↑ 72.33%
Net Income
$-335.2M
↓ 15.48%
Net Profit Margin
-164.97%
↑ 171.39%
FY21Y/Y Change
Revenue
$41.4K
↓ 99.98%
Net Income
$1.6B
↓ 578.71%
Net Profit Margin
3.9M%
↑ 3875445.71%
FY22Y/Y Change
Revenue
$14.2M
↑ 34288.66%
Net Income
$-74.6M
↓ 104.65%
Net Profit Margin
-523.56%
↓ 3875804.3%
FY23Y/Y Change
Revenue
$26.8M
↑ 88.36%
Net Income
$-352.1M
↑ 372.25%
Net Profit Margin
-1.3K%
↓ 789.07%
Q2 FY23Q/Q Change
Revenue
$6.7M
↑ 19.66%
Net Income
$-83.8M
↑ 17.34%
Net Profit Margin
-1.2K%
↑ 24.76%
Q3 FY23Q/Q Change
Revenue
$7.4M
↑ 10.24%
Net Income
$-91.3M
↑ 8.97%
Net Profit Margin
-1.2K%
↑ 14.33%
Q4 FY23Q/Q Change
Revenue
$7.1M
↓ 4.0%
Net Income
$-95.9M
↑ 5.05%
Net Profit Margin
-1.4K%
↓ 116.43%
Q1 FY24Q/Q Change
Revenue
$8.2M
↑ 15.29%
Net Income
$-81.5M
↓ 15.0%
Net Profit Margin
-995.84%
↑ 354.86%
Q2 FY24Q/Q Change
Revenue
$8.6M
↑ 5.2%
Net Income
$-96.1M
↑ 17.87%
Net Profit Margin
-1.1K%
↓ 119.87%
Q3 FY24Q/Q Change
Revenue
$9.0M
↑ 4.05%
Net Income
$947.9M
↓ 1086.2%
Net Profit Margin
10.6K%
↑ 11690.4%
FY18Y/Y Change
Profit
$93.0M
↑ 116.2%
FY19Y/Y Change
Profit
$116.6M
↑ 25.38%
FY20Y/Y Change
Profit
$200.4M
↑ 71.87%
FY21Y/Y Change
Profit
$-18.8M
↓ 109.37%
FY22Y/Y Change
Profit
$12.5M
↓ 166.76%
FY23Y/Y Change
Profit
$17.3M
↑ 38.15%
Q2 FY23Q/Q Change
Profit
$5.6M
↑ 10.86%
Q3 FY23Q/Q Change
Profit
$6.8M
↑ 20.74%
Q4 FY23Q/Q Change
Profit
$5.1M
↓ 24.42%
Q1 FY24Q/Q Change
Profit
$6.2M
↑ 21.51%
Q2 FY24Q/Q Change
Profit
$5.5M
↓ 11.06%
Q3 FY24Q/Q Change
Profit
$8.2M
↑ 48.02%
FY18Y/Y Change
Operating Cash Flow
$-304.4M
↑ 6.73%
Investing Cash Flow
$-273.8M
↑ 372.86%
Financing Cash Flow
$546.0M
↑ 91.51%
FY19Y/Y Change
Operating Cash Flow
$-370.6M
↑ 21.75%
Investing Cash Flow
$91.4M
↓ 133.39%
Financing Cash Flow
$289.6M
↓ 46.96%
FY20Y/Y Change
Operating Cash Flow
$-290.8M
↓ 21.55%
Investing Cash Flow
$75.7M
↓ 17.16%
Financing Cash Flow
$261.5M
↓ 9.7%
FY21Y/Y Change
Operating Cash Flow
$-407.3M
↑ 40.09%
Investing Cash Flow
$1.2B
↑ 1548.64%
Financing Cash Flow
$-765.8M
↓ 392.82%
FY22Y/Y Change
Operating Cash Flow
$-309.5M
↓ 24.02%
Investing Cash Flow
$243.3M
↓ 80.52%
Financing Cash Flow
$2.4M
↓ 100.31%
Q2 FY23Q/Q Change
Operating Cash Flow
$-66.7M
↓ 29.87%
Investing Cash Flow
$47.1M
↓ 18.18%
Financing Cash Flow
$237.0K
↓ 90.39%
Q3 FY23Q/Q Change
Operating Cash Flow
$-61.6M
↓ 7.65%
Investing Cash Flow
$39.3M
↓ 16.52%
Financing Cash Flow
$1.9M
↑ 694.09%

Agios Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Agios Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Agios Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc.
-43.26%
-23.01%
46.3%
1.61%
-29.71%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-6.55%
-32.6%
-21.28%
12.81%
90.81%
Biontech Se
Biontech Se
-2.77%
44.55%
1.43%
-55.8%
195.97%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
-5.94%
-2.2%
22.08%
40.33%
105.82%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
-12.23%
-13.26%
-0.52%
86.14%
86.27%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc.
2.95
2.95
0.0
11.21
0.54
-0.18
NA
28.53
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
32.84
NA
1.07
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc.
Buy
$2.0B
-29.71%
2.95
2051.38%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
90.81%
17.67
33.61%
Biontech Se
Biontech Se
Buy
$27.3B
195.97%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Buy
$31.3B
105.82%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$105.8B
86.27%
32.84
-4.51%

About Agios Pharmaceuticals

at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Organization
Agios Pharmaceuticals
Employees
383
CEO
Mr. Brian M. Goff M.B.A.
Industry
Health Technology

Management People of Agios Pharmaceuticals

NameTitle
Mr. Brian M. Goff M.B.A.
CEO & Director
Ms. Cecilia Jones
Chief Financial Officer
Mr. James William Burns
Corporate Secretary & Chief Legal Officer
Dr. Sarah Gheuens M.D., Ph.D.
Chief Medical Officer and Head of Research & Development
Ms. Tsveta Milanova
Chief Commercial Officer
Dr. Lewis Clayton Cantley Ph.D.
Founder
Dr. Tak Wah Mak D.Sc., FRSC, Ph.D.
Founder
Dr. Craig B. Thompson M.D.
Founder
Dr. Shin-San Su Ph.D.
Founder
Mr. T. J. Washburn
VP, Controller & Principal Accounting Officer

Important FAQs about investing in Agios Pharmaceuticals from India :

What is Agios Pharmaceuticals share price today?

Agios Pharmaceuticals share price today stands at $33.40, Open: $33.87 ; Previous Close: $34.37 ; High: $34.41 ; Low: $32.91 ; 52 Week High: $62.58 ; 52 Week Low: $20.96. The stock opens at $33.87, after a previous close of $34.37. The stock reached a daily high of $34.41 and a low of $32.91, with a 52-week high of $62.58 and a 52-week low of $20.96.

Can Indians buy Agios Pharmaceuticals shares?

Yes, Indians can invest in the Agios Pharmaceuticals (AGIO) from India.

With INDmoney, you can buy Agios Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Agios Pharmaceuticals at zero transaction cost.

How can I buy Agios Pharmaceuticals shares from India?

It is very easy to buy Agios Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Agios Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Agios Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Agios Pharmaceuticals stocks?

To start investing in Agios Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Agios Pharmaceuticals

Today’s highest price of Agios Pharmaceuticals (AGIO) is $34.41.

Today’s lowest price of Agios Pharmaceuticals (AGIO) is $32.91.

What is today's market capitalisation of Agios Pharmaceuticals

Today's market capitalisation of Agios Pharmaceuticals AGIO is 2.0B

What is the 52 Week High and Low Range of Agios Pharmaceuticals

  • 52 Week High

    $62.58

  • 52 Week Low

    $20.96

What are the historical returns of Agios Pharmaceuticals?

  • 1 Month Returns

    -43.26%

  • 3 Months Returns

    -23.01%

  • 1 Year Returns

    46.3%

  • 5 Years Returns

    -29.71%

Who is the Chief Executive Officer (CEO) of Agios Pharmaceuticals

Mr. Brian M. Goff M.B.A. is the current Chief Executive Officer (CEO) of Agios Pharmaceuticals.